Department of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.
Methods Mol Biol. 2024;2737:397-404. doi: 10.1007/978-1-0716-3541-4_36.
Pentobarbital is a short-acting barbiturate with anticonvulsant and sedative-hypnotic properties. Pentobarbital may be used to induce sedation, control seizures, induce coma, and to manage patients with traumatic brain injury. In traumatic brain injury, use of pentobarbital is known to reduce both cerebral blood flow and oxygen consumption, which reduces intracranial pressure and cerebral ischemia. As there are currently no known commercially available methods for quantification, a quick and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) method is described here for the quantification of pentobarbital. The analyte and internal standard, D5-pentobarbital, were extracted from human serum via solid phase extraction prior to LC-MS/MS analysis utilizing electrospray ionization (ESI) in negative ionization mode. Confirmation and quantitation of pentobarbital was performed using multiple reaction monitoring (MRM). The method was linear from 0.5 to 100 μg/mL with imprecision less than 5% coefficient of variability. Pentobarbital eluted at 2.61 min and the total run time was 7 min. The method only requires 100 μL of serum due to the high physiologic concentrations required for sedation/coma.
戊巴比妥是一种短效巴比妥类药物,具有抗惊厥和镇静催眠作用。戊巴比妥可用于诱导镇静、控制癫痫发作、诱导昏迷,以及治疗创伤性脑损伤患者。在创伤性脑损伤中,使用戊巴比妥可降低脑血流量和耗氧量,从而降低颅内压和脑缺血。由于目前尚无已知的商业可量化方法,因此本文描述了一种快速可靠的液相色谱-串联质谱(LC-MS/MS)法,用于定量检测戊巴比妥。分析物和内标物 D5-戊巴比妥,在 LC-MS/MS 分析前通过固相萃取从人血清中提取,利用电喷雾电离(ESI)在负离子模式下进行。采用多重反应监测(MRM)进行戊巴比妥的确认和定量。该方法的线性范围为 0.5 至 100μg/mL,变异系数小于 5%。戊巴比妥的洗脱时间为 2.61 分钟,总运行时间为 7 分钟。由于镇静/昏迷所需的高生理浓度,该方法仅需 100μL 血清。